BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 8808498)

  • 1. An examination of the effect of combined cyclical hormone replacement therapy on lipoprotein(a) and other lipoproteins.
    Haines CJ; Chung TK; Masarei JR; Tomlinson B; Lau JT
    Atherosclerosis; 1996 Jan; 119(2):215-22. PubMed ID: 8808498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of hormone replacement therapy, tibolone and raloxifene on serum lipids, apolipoprotein A1, apolipoprotein B and lipoprotein(a) in Greek postmenopausal women.
    Christodoulakos GE; Lambrinoudaki IV; Panoulis CP; Papadias CA; Kouskouni EE; Creatsas GC
    Gynecol Endocrinol; 2004 May; 18(5):244-57. PubMed ID: 15346660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal women.
    Tilly-Kiesi M; Kahri J; Pyörälä T; Puolakka J; Luotola H; Lappi M; Lahdenperä S; Taskinen MR
    Atherosclerosis; 1997 Mar; 129(2):249-59. PubMed ID: 9105568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy lowers plasma Lp(a) concentrations. Comparison of cyclic transdermal and continuous estrogen-progestin regimens.
    Taskinen MR; Puolakka J; Pyörälä T; Luotola H; Bjäörn M; Kääriänen J; Lahdenperä S; Ehnholm C
    Arterioscler Thromb Vasc Biol; 1996 Oct; 16(10):1215-21. PubMed ID: 8857916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sequential combined transdermal and oral hormone replacement therapies on serum lipid and lipoproteins in postmenopausal women.
    Sendag F; Karadadas N; Ozsener S; Bilgin O
    Arch Gynecol Obstet; 2002 Jan; 266(1):38-43. PubMed ID: 11998963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of conjugated equine estrogen and medroxyprogesterone acetate on lipoprotein(a) and other lipoproteins in japanese postmenopausal women with and without dyslipidemia.
    Sumino H; Ichikawa S; Sakamoto H; Sawada Y; Kumakura H; Takayama Y; Sakamaki T; Kurabayashi M
    Horm Res; 2004; 62(1):1-9. PubMed ID: 15031614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy.
    Kim CJ; Min YK; Ryu WS; Kwak JW; Ryoo UH
    Arch Intern Med; 1996 Aug 12-26; 156(15):1693-700. PubMed ID: 8694668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of progestogen on lipids, lipoproteins and apolipoproteins during transdermal estrogen replacement therapy with and without medroxyprogesterone acetate.
    Castelo-Branco C; Casals E; Sanllehy C; Duran M; Fortuny A; Vanrell JA
    J Reprod Med; 1996 Nov; 41(11):833-8. PubMed ID: 8951134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phasic serum lipid excursions occur during cyclical oral conjugated oestrogens but not during transdermal oestradiol sequentially combined with oral medroxyprogesterone acetate.
    Lemay A; Dodin S; Cédrin I; T-Lemay L
    Clin Endocrinol (Oxf); 1995 Apr; 42(4):341-51. PubMed ID: 7750187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of oral and transdermal hormone replacement therapy on lipid profile and Lp(a) level in menopausal women with hypercholesterolemia.
    Perrone G; Stefanutti C; Galoppi P; Anelli G; Capri O; Lucani G; Vivenzio A; Mazzarella B; Zichella L
    Int J Fertil Menopausal Stud; 1996; 41(6):509-15. PubMed ID: 9010744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effects of estradiol and progesterone on insulin, lipids and lipoproteins in postmenopausal women: a pilot study.
    Cheung AP
    Maturitas; 2000 Apr; 35(1):45-50. PubMed ID: 10802399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a new cyclical sequential postmenopausal HRT on lipoprotein, apoprotein and thrombophilia profile.
    Habiba M; Akkad A; al-Azzawi F
    Eur J Obstet Gynecol Reprod Biol; 1995 Sep; 62(1):89-94. PubMed ID: 7493716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in plasma lipoprotein and apolipoprotein composition in relation to oral versus percutaneous administration of estrogen alone or in cyclic association with utrogestan in menopausal women.
    Moorjani S; Dupont A; Labrie F; De Lignieres B; Cusan L; Dupont P; Mailloux J; Lupien PJ
    J Clin Endocrinol Metab; 1991 Aug; 73(2):373-9. PubMed ID: 1649840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of percutaneous oestrogen replacement therapy on Lp(a) and other lipoproteins.
    Haines CJ; Chung TK; Masarei JR; Tomlinson B; Lau JT
    Maturitas; 1995 Nov; 22(3):219-25. PubMed ID: 8746879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum lipids, lipoproteins, and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxyprogesterone derivatives.
    Haarbo J; Hassager C; Jensen SB; Riis BJ; Christiansen C
    Am J Med; 1991 May; 90(5):584-9. PubMed ID: 1827568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oral estradiol on Lp(a) and other lipoproteins in postmenopausal women. A randomized, double-blind, placebo-controlled, crossover study.
    Haines C; Chung T; Chang A; Masarei J; Tomlinson B; Wong E
    Arch Intern Med; 1996 Apr; 156(8):866-72. PubMed ID: 8774205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a lipid lowering fibrate and hormone replacement therapy on serum lipids and lipoproteins in overweight postmenopausal women with elevated triglycerides.
    Nerbrand C; Nyberg P; Nordström L; Samsioe G
    Maturitas; 2002 May; 42(1):55-62. PubMed ID: 12020980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
    Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of estrogen-progestin replacement therapy on plasma lipids and lipoproteins in postmenopausal women.
    Rodriguez-Alemán F; Torres JM; Cuadros JL; Ruiz E; Ortega E
    Endocr Res; 2000 May; 26(2):263-73. PubMed ID: 10921452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral 17 beta-estradiol continuously combined with dydrogesterone lowers serum lipoprotein(a) concentrations in healthy postmenopausal women.
    Mijatovic V; Kenemans P; Netelenbos JC; Peters-Muller ER; van Kamp GJ; Voetberg GA; van de Weijer PH; van der Mooren MJ
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3543-7. PubMed ID: 9360504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.